News
The big health insurers Moody's rates now face shrinking profit margins at the Medicaid plans they manage for state ...
Nestle has launched a review of its underperforming vitamins business that could lead to the divestment of some brands, it said on Thursday, after reporting its first-half sales volumes grew more ...
CVS has halted UK acquisitions and focused on Australian expansion due to a probe by the UK’s competition watchdog into the pet sector. The vet group has also delayed its full-year results until ...
Biosimilars and Biologics Market Driven by aging populations and patent cliffs, the biosimilars & biologics market will grow from ~$531B in ...
Morningstar Investment Services made headlines by reducing their stake in CVS Health, a move shaking investor confidence.
Today’s Forbes CMO newsletter takes a deep dive into the UN Global Compact’s blueprint that outlines how marketing leaders ...
Elevance Health (ELV) just surged a massive 191% in trading volume, turning heads in the stock market. On July 22, 2025, the ...
We provide a methodology for selecting high-growth dividend-paying stocks. Click here to read more about the basis of the final list of ten stocks.
6d
Zacks Investment Research on MSNCVS Health (CVS) Dips More Than Broader Market: What You Should KnowCVS Health (CVS) closed the most recent trading day at $61.96, moving -2.12% from the previous trading session. This change lagged the S&P 500's 0.01% loss on the day. Elsewhere, the Dow lost 0.32%, ...
To reflect our sharpened commercial focus and commitment to strategic growth we are announcing several key leadership changes. The changes ...
The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results